In vivo liver visualizations with magnetic particle imaging based on the calibration measurement approach

Magnetic particle imaging (MPI) facilitates the rapid determination of 3D in vivo magnetic nanoparticle distributions. In this work, liver MPI following intravenous injections of ferucarbotran (Resovist®) was studied. The image reconstruction was based on a calibration measurement, the so called system function. The application of an enhanced system function sample reflecting the particle mobility and aggregation status of ferucarbotran resulted in significantly improved image reconstructions. The finding was supported by characterizations of different ferucarbotran compositions with the magnetorelaxometry and magnetic particle spectroscopy technique. For instance, similar results were obtained between ferucarbotran embedded in freeze-dried mannitol sugar and liver tissue harvested after a ferucarbotran injection. In addition, the combination of multiple shifted measurement patches for a joint reconstruction of the MPI data enlarged the field of view and increased the covering of liver MPI on magnetic resonance images noticeably.

[1]  M. Ferrari,et al.  Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI) , 2007, Biomedical microdevices.

[2]  L. Trahms,et al.  Aggregation behaviour of magnetic nanoparticle suspensions investigated by magnetorelaxometry , 2006 .

[3]  John B Weaver,et al.  Magnetic nanoparticle temperature estimation. , 2009, Medical physics.

[4]  R. Carson,et al.  Evaluation of bias and variance in low-count OSEM list mode reconstruction , 2015, Physics in medicine and biology.

[5]  Keiji Enpuku,et al.  Characterization of superparamagnetic Fe3O4 nanoparticles by fluxgate magnetorelaxometry for use in biomedical applications , 2008 .

[6]  Bernhard Gleich,et al.  Quantitative “Hot-Spot” Imaging of Transplanted Stem Cells Using Superparamagnetic Tracers and Magnetic Particle Imaging , 2015, Tomography.

[7]  T J Brady,et al.  Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system. , 1987, Radiology.

[8]  Tobias Knopp,et al.  Magnetic Particle / Magnetic Resonance Imaging: In-Vitro MPI-Guided Real Time Catheter Tracking and 4D Angioplasty Using a Road Map and Blood Pool Tracer Approach , 2016, PloS one.

[9]  T Knopp,et al.  Online reconstruction of 3D magnetic particle imaging data , 2016, Physics in medicine and biology.

[10]  Tobias Knopp,et al.  Sensitivity Enhancement in Magnetic Particle Imaging by Background Subtraction , 2016, IEEE Transactions on Medical Imaging.

[11]  T Knopp,et al.  Joint reconstruction of non-overlapping magnetic particle imaging focus-field data , 2015, Physics in medicine and biology.

[12]  M. Mack,et al.  Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient. , 1996, Investigative radiology.

[13]  T Knopp,et al.  Geometry planning and image registration in magnetic particle imaging using bimodal fiducial markers. , 2016, Medical physics.

[14]  Bo Zheng,et al.  Magnetic particle imaging (MPI) for NMR and MRI researchers. , 2013, Journal of magnetic resonance.

[15]  Kenneth W Dunn,et al.  A practical guide to evaluating colocalization in biological microscopy. , 2011, American journal of physiology. Cell physiology.

[16]  Bo Zheng,et al.  Quantitative Magnetic Particle Imaging Monitors the Transplantation, Biodistribution, and Clearance of Stem Cells In Vivo , 2016, Theranostics.

[17]  Tobias Knopp,et al.  Increasing the sensitivity for stem cell monitoring in system-function based magnetic particle imaging , 2016, Physics in medicine and biology.

[18]  B Gleich,et al.  A simulation study on the resolution and sensitivity of magnetic particle imaging , 2007, Physics in medicine and biology.

[19]  Kenya Murase,et al.  Magnetic Particle Imaging for Magnetic Hyperthermia Treatment: Visualization and Quantification of the Intratumoral Distribution and Temporal Change of Magnetic Nanoparticles in Vivo , 2016 .

[20]  Jürgen Rahmer,et al.  Fast MPI Demonstrator with Enlarged Field of View , 2010 .

[21]  B Gleich,et al.  First experimental evidence of the feasibility of multi-color magnetic particle imaging , 2015, Physics in medicine and biology.

[22]  Bernhard Gleich,et al.  Tomographic imaging using the nonlinear response of magnetic particles , 2005, Nature.

[23]  Olaf Kosch,et al.  Concentration Dependent MPI Tracer Performance , 2016 .

[24]  Frank Ludwig,et al.  Magnetorelaxometry of magnetic nanoparticles in magnetically unshielded environment utilizing a differential fluxgate arrangement , 2005 .

[25]  Tobias Knopp,et al.  Combined Preclinical Magnetic Particle Imaging and Magnetic Resonance Imaging: Initial Results in Mice , 2015, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[26]  Thorsten M. Buzug,et al.  Magnetic Particle Imaging: An Introduction to Imaging Principles and Scanner Instrumentation , 2012 .

[27]  Justin J. Konkle,et al.  Magnetic Particle Imaging With Tailored Iron Oxide Nanoparticle Tracers , 2015, IEEE Transactions on Medical Imaging.

[28]  D. D. Stark,et al.  Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years. , 1990, AJR. American journal of roentgenology.

[29]  M Hasegawa,et al.  Magnetic Iron Oxide Particles Coated with Carboxydextran for Parenteral Administration and Liver Contrasting , 1997, Acta radiologica.